Dr. Michael Poulter, CSO of OB Pharmaceuticals to present at Eilat XIV.
posted in: Eilat XIV, Michael Poulter, Uncategorized 0
LONDON, ONTARIO May 2, 2018 — OB Pharmaceuticals was invited to present the details of its drug development program of … Read More